Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 36
- 试验地点
- 1
- 主要终点
- Number of determinants which are privileged by the patients to choose a treatment
研究概览
简要总结
Reflexion on the therapeutic strategies to implement in patients at the end of life is advancing rapidly in France. However, beyond the choices presented to patients, sometimes even the decision to carry on, to limit or to stop treatments is also questioned. This decision is subjective; it is influenced by the patient's representation system (emotions, beliefs, values, practices, etc). In addition, even though he or she is the focus of the decision, the patient is not alone; other actors, accompanying the patient, play an important role in the final decision making. These actors, namely the doctors and close relatives, are also influenced in their decision making. This coexistence of representation systems may interfere with objective indicators that help in decision making (functional, clinical and biological) or with the knowledge acquired by doctors in their training and may complicate the decision-making process.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •I- PATIENTS
- •men or women
- •who have been informed about the study
- •and who have provided verbal consent to take part in the study
- •able to understand written and spoken French
- •with non-resectable metastatic cancer of: the colon, or the rectosigmoid junction or the stomach or bile ducts or rectum or gastrointestinal neuroendocrine tumor or lung (not small-cell cancer) or pancreas
- •with a caregiver designated as the principal caregiver (family, friend, neighbour)
- •who has consented to the principal caregiver taking part in a qualitative interview
- •able to take part in an interview lasting roughly one hour
- •II- CAREGIVERS
- •men or women
- •who have been informed about the study
- •who have provided verbal consent to take part in the study
- •able to understand written and spoken French
- •able to follow an interview lasting roughly one hour
- •III-DOCTORS
- •men or women
- •who have been informed about the study
- •who have provided verbal consent to take part in the study
- •specialised in specific organ or oncologist prescriber
排除标准
- •I- PATIENTS
- •under guardianship or ward of court
- •with a severe handicap (neurological disease: Parkinson, Alzheimer, other dementia, multiple sclerosis, severe mental retardation etc.)
- •II- CAREGIVERS
- •under guardianship or ward of court,
- •with a severe handicap (neurological disease: Parkinson, Alzheimer, other dementia, multiple sclerosis...),
- •with severe mental retardation impairing ability to understand.
结局指标
主要结局
Number of determinants which are privileged by the patients to choose a treatment
时间窗: through study completion, an average of 18 months
Type of determinants which are privileged by the patients to choose a treatment
时间窗: through study completion, an average of 18 months
次要结局
未报告次要终点
